Global Research Risk and Alpha amid Rising Volatility Cathy Fang Analyst S1460518100001 cathy.fang@ubs.com +86 21 3866 8891 July 2025 This document has been prepared by UBS Securities Co. Limited. UBS does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. ...

Core Insights - The indicated dividend net changes for U.S. domestic common stocks increased by $7.4 billion in Q2 2025, a decline from $15.3 billion in Q1 2025 and $16.0 billion in Q2 2024 [1][6] - For the 12-month period ending June 2025, the net dividend rate increased by $44.1 billion, down from $54.6 billion for the same period in 2024 [2][6] - Dividend growth has declined due to concerns over cash commitments amid uncertainties regarding tariffs and their economic impact [3][4] Dividend Increases - In Q2 2025, U.S. common dividend increases totaled $9.8 billion, a decrease of 49.8% from $19.5 billion in Q1 2025 and down 52.1% from $20.4 billion in Q2 2024 [6][7] - For the 12-month period ending June 2025, total dividend increases were $57.6 billion, down 26.8% from $78.7 billion in the previous year [8][6] - A total of 480 dividend increases were reported in Q2 2025, compared to 539 in Q2 2024, marking a 10.9% year-over-year decrease [7] Dividend Decreases - In Q2 2025, there were 38 issues that decreased dividends, an 81.0% year-over-year increase from 21 issues in Q2 2024 [15] - Dividend decreases amounted to $2.3 billion in Q2 2025, compared to $4.4 billion in Q2 2024 [15] - For the 12-month period ending June 2025, 155 issues decreased their dividend payments, down from 175 in the previous year [15] Future Outlook - The second half of 2025 may see stronger dividend performance as companies await clarity on economic policies and tariff resolutions [4] - Q3 2025 is expected to show improvements in dividend payments, particularly from large banks following positive stress test results [4] - The S&P 500 is projected to achieve a record in dividend payments for 2025, with a 6% increase anticipated, down from an earlier expectation of 8% [4]

As Conagra Brands, Inc. CAG gears up to unveil its fourth-quarter earnings on July 10, all eyes are on whether the food giant can maintain its profitability amid shifting market dynamics and a declining revenue forecast—while investors weigh the allure of a tempting dividend yield that could reshape their portfolios.Analysts expect the company to report quarterly earnings of 61 cents per share, in line with the 61 cents per share reported in the year-ago period. Conagra Brands is projected to report quarter ...

Core Insights - The article discusses the author's background in analytics and accounting, highlighting over 10 years of experience in the investment arena, starting as an analyst and progressing to a management role [1]. Group 1 - The author holds a master's degree in Analytics from Northwestern University and a bachelor's degree in Accounting [1]. - The author has a personal interest in dividend investing and aims to share insights with the Seeking Alpha community [1].

Group 1 - AdvanSix Inc. (NYSE: ASIX) is trading at low multiples due to the cyclical nature of its revenue and the industry it operates in, which is considered one of the worst in US markets [1] - The market is believed to be mispricing AdvanSix, indicating potential undervaluation [1] Group 2 - The analysis is grounded in a mix of financial education, including CFA studies and valuation books, focusing on fundamental analysis while considering other relevant perspectives [1] - The investment research approach is primarily bottom-up, covering sectors such as utilities, consumer discretionary, consumer staples, REITs, and materials across the Americas [1] - The focus is on stocks with a mid-term return perspective, specifically within a 1 to 3-year timeframe [1]

Core Insights - The article emphasizes the effectiveness of investing in dividend growth stocks and reinvesting dividends as a strategy for long-term wealth growth [1] Group 1: Investment Strategy - The individual investor has explored various investment styles over 25 years, concluding that dividend growth stocks are a reliable method for wealth accumulation [1] - The investor has experience with a diverse range of investment vehicles, including stocks, options, ETFs, treasury notes, and mutual funds [1] - The blog, HarvestingDividends.com, focuses on providing information about S&P Dividend Aristocrats and other dividend growth stocks [1]

Core Viewpoint - The private sector is experiencing job losses, which is beneficial for earnings season and dividend growth stocks due to easing wage pressures and lower inflation, leading to better profit margins and dividend hikes [2]. Dividend Growth Stocks Dividend Growth Stock 1: T-Mobile US (TMUS) - T-Mobile US initiated a new dividend program in 2023 and raised its dividend by 35% to 88 cents per share after merging with Sprint [6][8]. - The company is expanding its margins and free cash flow, which supports its dividend growth strategy [7][9]. Dividend Growth Stock 2: Amphenol (APH) - Amphenol has seen significant growth, particularly in AI-related applications, with total orders increasing by nearly 60% year-over-year in Q1 2025 [12]. - The company raised its dividend by 50% last year, marking one of its largest increases [12]. Dividend Growth Stock 3: California Resources (CRC) - California Resources has shifted towards green-energy initiatives and has increased its quarterly distribution by 128% since its initiation [15]. - The company has been profitable since emerging from bankruptcy in 2021 and has seen its shares triple since relisting [16]. Dividend Growth Stock 4: RLJ Lodging Trust (RLJ) - RLJ Lodging Trust reduced its dividend significantly during the pandemic but has since increased it by 1,400% from its low point [19]. - Analysts project a 40% AFFO payout ratio for RLJ, indicating potential for further dividend growth [20]. Dividend Growth Stock 5: Coca-Cola Consolidated (COKE) - Coca-Cola Consolidated has shown consistent top-line growth and recently announced a $16-per-share special dividend, along with a quintupled regular payout to $2.50 per share [24]. - The company currently pays out only 15% of its earnings as dividends, suggesting room for future increases [24].

Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that grows through reinvestment and annual increases [1] Group 2 - The article expresses personal opinions and is not intended as investment advice [2][3] - It emphasizes the importance of conducting individual research before making investment decisions [2]

AbbVie - AbbVie is a pharmaceutical leader with a strong portfolio, particularly in immunology with products Skyrizi and Rinvoq, achieving a revenue increase of 8.4% year-over-year to $13.3 billion in Q1, with adjusted earnings per share at $2.46, a 6.5% increase [3][4] - Skyrizi generated $3.4 billion in sales, a 70.5% year-over-year increase, while Rinvoq's revenue was $1.7 billion, up 57.2% year-over-year; management forecasts combined annual sales exceeding $31 billion by 2027, significantly higher than the previous year's $17.7 billion [4][5] - AbbVie has a deep pipeline with approximately 90 products in development, allowing it to navigate patent cliffs and maintain long-term success [5][7] - AbbVie has increased its dividends by 310% since 2013 and has a track record of 53 consecutive years of payout increases, indicating strong potential for sustained passive income [8] Abbott Laboratories - Abbott Laboratories is a leader in the medical device space, with a diversified operation across diagnostics, pharmaceuticals, and nutrition, which helps mitigate challenges in specific segments [9][10] - The diabetes care segment, particularly the FreeStyle Libre continuous glucose monitoring system, has been a significant growth driver, becoming the most successful medical device in history in terms of dollar sales [11][12] - Abbott has increased its dividends by almost 146% over the past decade, reinforcing its reputation as a Dividend King and indicating a strong foundation for long-term dividend growth [13]

In the case of REITs ( XLRE ), I think in the next few years, investors will see some nice price appreciation as the sector sees tailwinds from lower interest rates.Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their own due diligence. I'm a Navy veteran who enjoys dividend ...